Cryo-Touch III Refinement Study Investigational Plan

Inclusion Criteria: * Age 30-70 years * Subject has a glabellar and/or forehead wrinkle rating by investigator of at least 2 in animation on the 5-point Wrinkle Scale (5WS)\* * Subject has signed institutional review board (IRB)-approved informed consent form Exclusion Criteria: * Subject takes any medication or dietary supplement regularly that affects blood clotting (e.g., Coumadin, aspirin, clopidogrel) or increases the risk of bleeding/bruising * Subject has had prior surgery that alters the subcutaneous anatomy of the target treatment sites * The investigator is unable to substantially lessen facial lines by physical separation * Subject has undergone another facial cosmetic procedures at or above the level of the cheekbones within the past 6 months * Subject is participating in another facial cosmetic research study Patient has any of following conditions: * History of facial nerve palsy * Marked facial asymmetry * Ptosis * Excessive dermatochalasis * Deep dermal scarring * Thick sebaceous skin * History of neuromuscular disorder * Chronic dry eye symptoms * Allergy or intolerance to lidocaine * Other local skin condition (eg, skin infection) at target treatment site * Any physical or psychiatric condition that in the investigator's opinion would prevent adequate study participation